The Majority of Adrenocorticotropin Receptor (Melanocortin 2 Receptor) Mutations Found in Familial Glucocorticoid Deficiency Type 1 Lead to Defective Trafficking of the Receptor to the Cell Surface
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
CONTEXT: There are at least 24 missense, nonconservative mutations found in the ACTH receptor [melanocortin 2 receptor (MC2R)] that have been associated with the autosomal recessive disease familial glucocorticoid deficiency (FGD) type 1. The characterization of these mutations has been hindered by difficulties in establishing a functional heterologous cell transfection system for MC2R. Recently, the melanocortin 2 receptor accessory protein (MRAP) was identified as essential for the trafficking of MC2R to the cell surface; therefore, a functional characterization of MC2R mutations is now possible. OBJECTIVE: Our objective was to elucidate the molecular mechanisms responsible for defective MC2R function in FGD. METHODS: Stable cell lines expressing human MRAPalpha were established and transiently transfected with wild-type or mutant MC2R. Functional characterization of mutant MC2R was performed using a cell surface expression assay, a cAMP reporter assay, confocal microscopy, and coimmunoprecipitation of MRAPalpha. RESULTS: Two thirds of all MC2R mutations had a significant reduction in cell surface trafficking, even though MRAPalpha interacted with all mutants. Analysis of those mutant receptors that reached the cell surface indicated that four of six failed to signal, after stimulation with ACTH. CONCLUSION: The majority of MC2R mutations found in FGD fail to function because they fail to traffic to the cell surface.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, naturally occurring homozygous mutations of Asp 103 and 107 in MC2R, the equivalent conserved Asp residues in this receptor, lead to ACTH resistance/Familial Glucocorticoid Deficiency (47).”
From ACTH Antagonists (2016) · cites this paper as [47]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The cloning of a family of genes that encode the melanocortin receptors
Mountjoy, K. G., Robbins, L. S., Mortrud, M. T., & Cone, R. D. (1992) · Science · doi:10.1126/science.1325670 · Cited by 1,635 · cited 1×
“MC2R is one of five melanocortin receptors (MCRs) ( 8 ).”
BackgroundSequence Alignment of the G-Protein Coupled Receptor Superfamily
PROBST, W. C., SNYDER, L. A., SCHUSTER, D. I., BROSIUS, J., & SEALFON, S. C. (1992) · DNA and Cell Biology · doi:10.1089/dna.1992.11.1 · Cited by 845 · cited 1×
“This is an interesting mutation because it lies in the asparagine-argininetyrosine (DRY) region in the second intracellular loop, which is themostconservedregionofallGPCRs(20).Indeed,thearginine residue in this motif is the only amino acid conserved among all subclass 1 receptors ( 21 ).”
BackgroundTherapeutic approaches to protein-misfolding diseases
Cohen, F. E., & Kelly, J. W. (2003) · Nature · doi:10.1038/nature02265 · Cited by 800 · cited 1×
“Receptor ligands or enzyme inhibitors, which selectively recognize the mutant proteins and rescue conformational mutants, are referred to as pharmacological chaperones, and these present promising therapeutic avenues (33, 34 ).”
BackgroundQuality control in the endoplasmic reticulum protein factory
Sitia, R., & Braakman, I. (2003) · Nature · doi:10.1038/nature02262 · Cited by 688
Influence of molecular and chemical chaperones on protein folding
Welch, W. J., & Brown, C. R. (1996) · Cell Stress & Chaperones · doi:10.1379/1466-1268(1996)001<0109:iomacc>2.3.co;2 · Cited by 495 · cited 1×
“Thesesmallmolecules,namedchemicalchaperones,arethought to nonselectively stabilize mutant proteins and facilitate their folding ( 32 ).”
BackgroundMetherell, L. A., Chapple, J. P., Cooray, S., David, A., Becker, C., Rüschendorf, F., Naville, D., Begeot, M., Khoo, B., Nürnberg, P., et al. (2005) · Nature Genetics · doi:10.1038/ng1501 · Cited by 437 · cited 2×
“Interaction of mutated MC2R with MRAP was assessed by Co-IP and immunoblotting as previously described ( 13 , 14) CHO cells were transiently transfected with MRAP-Flag, and mutant HA-MC2R constructsand24haftertransfection,cellswerelysedwith0.1% D-dodecyl- -maltoside in PBS in the presence of protease inhibitors.”
BackgroundMethodThe Highly Conserved DRY Motif of Class A G Protein-Coupled Receptors: Beyond the Ground State
Rovati, G. E., Capra, V., & Neubig, R. R. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.029470 · Cited by 392 · cited 1×
“Interestingly, substitution of the next amino acid in the DRY motif, the Y129C mutant, caused significantintracellularretention.Tyrosineistheleastconservedof the triad sequence, and in other GPCRs, this tyrosine mutation often only marginally affects receptor function, if at all ( 23 ).”
BackgroundMechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy
Mendes, H. F., van der Spuy, J., Chapple, J. P., & Cheetham, M. E. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.02.007 · Cited by 377 · cited 1×
“trafficking defects. These include rhodopsin mutations in retinitis pigmentosa ( 28 ), vasopressin 2 receptor mutations causing nephrogenic diabetes insipidus (29), and GnRH receptor point mutationscausinghypogonadotrophichypogonadism(30).The strict quality control mechanisms within cells ensure that improperly folded…”
BackgroundPharmacological chaperones: potential treatment for conformational diseases
Bernier, V., Lagacé, M., Bichet, D. G., & Bouvier, M. (2004) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2004.05.003 · Cited by 283 · cited 1×
“trafficking defects. These include rhodopsin mutations in retinitis pigmentosa (28), vasopressin 2 receptor mutations causing nephrogenic diabetes insipidus ( 29 ), and GnRH receptor point mutationscausinghypogonadotrophichypogonadism(30).The strict quality control mechanisms within cells ensure that improperly folded…”
BackgroundClark, A. J. L., Grossman, A., & McLoughlin, L. (1993) · The Lancet · doi:10.1016/0140-6736(93)90208-x · Cited by 272
Cited by
Marinko, J. T., Huang, H., Penn, W. D., Capra, J. A., Schlebach, J. P., & Sanders, C. R. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00532 · Cited by 252
The Year In G Protein-Coupled Receptor Research
Millar, R. P., & Newton, C. L. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0473 · Cited by 167
Phenotypic characteristics of familial glucocorticoid deficiency (FGD) type 1 and 2
Chung, T. L. L., Chan, L. F., Metherell, L. A., & Clark, A. J. L. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03663.x · Cited by 92
MOLECULAR EVOLUTION OF GPCRS: Melanocortin/melanocortin receptors
Dores, R. M., Londraville, R. L., Prokop, J., Davis, P., Dewey, N., & Lesinski, N. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0050 · Cited by 92
Familial glucocorticoid deficiency: New genes and mechanisms
Meimaridou, E., Hughes, C. R., Kowalczyk, J., Guasti, L., Chapple, J. P., King, P., Chan, L. F., Clark, A., & Metherell, L. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.12.010 · Cited by 95
ACTH Receptor (MC2R) Specificity: What Do We Know About Underlying Molecular Mechanisms?
Frīdmanis, D., Roga, A., & Kloviņš, J. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00013 · Cited by 91
“Nevertheless, such speculation is at least partially untrue in the case of ACTHR because the basic H170 is in the exact position occupied by an acidic residue in other MCRs, yet the loss of functional activity observed by Clark’s group (156) shows that it is still important.”
BackgroundInfluential60 YEARS OF POMC: Melanocortin receptors: evolution of ligand selectivity for melanocortin peptides
Dores, R. M., Liang, L., Davis, P. V., Thomas, A., & Petko, B. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0292 · Cited by 77
Intracellular signaling mechanisms of the melanocortin receptors: current state of the art
Rodrigues, A. R., Almeida, H., & Gouveia, A. M. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1800-3 · Cited by 64
“MRAP1 was further established as essential for MC2R trafficking and signaling [21, 50–53], a reason why 20 % of FGD type 2 patients have mutations in MRAP gene [1].”
BackgroundThe cAMP pathway and the control of adrenocortical development and growth
de Joussineau, C., Sahut-Barnola, I., Levy, I., Saloustros, E., Val, P., Stratakis, C. A., & Martinez, A. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.10.006 · Cited by 62
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript These mouse phenotypes reflect what is seen in human with Familial Glucocorticoid deficiency type 1, a disease mostly resulting from mutations in MC2R that impair its trafficking to the membrane (Chung et al., 2008).”
BackgroundPathophysiology of melanocortin receptors and their accessory proteins
Novoselova, T. V., Chan, L. F., & Clark, A. (2018) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2018.02.002 · Cited by 62
Current Insights Into Adrenal Insufficiency in the Newborn and Young Infant
Buonocore, F., McGlacken-Byrne, S. M., del Valle, I., & Achermann, J. C. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.619041 · Cited by 59
“MRAP trafficsMC2R to the adrenal cell membrane surface, so disruption of its function (usually due to splicing defects in exon 3) impairs ACTH signaling (68, 73, 74).”
BackgroundClark, A. J., Forfar, R., Hussain, M., Jerman, J., McIver, E., Taylor, D., & Chan, L. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00101 · Cited by 49
“Indeed, naturally occurring homozygous mutations of Asp 103 and 107 in MC2R, the equivalent conserved Asp residues in this receptor, lead to ACTH resistance/ Familial Glucocorticoid Deficiency (47).”
BackgroundElucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying Proteins
Kotliar, I. B., Lorenzen, E., Schwenk, J. M., Hay, D. L., & Sakmar, T. P. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000180 · Cited by 56
Berruien, N. N. A., & Smith, C. L. (2020) · Gene · doi:10.1016/j.gene.2020.144949 · Cited by 49
Dores, R. M. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00028 · Cited by 47
Meimaridou, E., Gooljar, S. B., Ramnarace, N., Anthonypillai, L., Clark, A., & Chapple, J. P. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-1020 · Cited by 45
Malik, S., Dolan, T. M., Maben, Z. J., & Hinkle, P. M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.668491 · Cited by 41
“Interestingly, missense mutations in human MC2 receptors responsible for clinical ACTH resistance do not prevent receptors from interacting with hMRAP but do prevent them from reaching the plasma membrane (23).”
BackgroundNovel Insight into Etiology, Diagnosis and Management of Primary Adrenal Insufficiency
Malikova, J., & Flück, C. E. (2014) · Hormone Research in Paediatrics · doi:10.1159/000363107 · Cited by 40
Effects of melanocortins on adrenal gland physiology
Chan, L. F., Metherell, L., & Clark, A. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.11.041 · Cited by 45
Molecular signatures of human melanocortin receptors for ligand binding and signaling
Yang, Y., & Harmon, C. M. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.04.025 · Cited by 44
Cryo-electron microscopy for GPCR research and drug discovery in endocrinology and metabolism
Duan, J., He, X., Li, S., & Xu, H. E. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-00957-1 · Cited by 47
ACTH Resistance: Genes and Mechanisms
Meimaridou, E., Hughes, C. R., Kowalczyk, J., Chan, L. F., Clark, A. J. L., & Metherell, L. A. (2013) · Endocrine Development · doi:10.1159/000342504 · Cited by 39
Isolated glucocorticoid deficiency: Genetic causes and animal models
Maharaj, A. V., Maudhoo, A., Chan, L. F., Novoselova, T. V., Prasad, R., Metherell, L., & Guasti, L. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.02.012 · Cited by 41
Marques, P., & Korbonits, M. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2018.11.001 · Cited by 37
Melanocortin receptor accessory proteins in adrenal gland physiology and beyond
Novoselova, T. V., Jackson, D., Campbell, D. C., Clark, A., & Chan, L. F. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0501 · Cited by 53
“The majority of MC2R mutations result in defective trafficking of the receptor to the plasma membrane (Chung et al. 2008).”
Liang, L., Angleson, J. K., & Dores, R. M. (2013) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2012.11.011 · Cited by 35
G Protein-Coupled Receptors: What a Difference a ‘Partner’ Makes
Roux, B. T., & Cottrell, G. S. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15011112 · Cited by 40
“The loss of function is brought about by the receptor’s failure to traffic appropriately to the cell-surface [137].”
ACTH signalling and adrenal development: lessons from mouse models
Novoselova, T. V., King, P., Guasti, L., Metherell, L., Clark, A., & Chan, L. F. (2019) · Endocrine Connections · doi:10.1530/ec-19-0190 · Cited by 38
Chan, L. F., Metherell, L., Krude, H., Ball, C., O’Riordan, S., Costigan, C., Lynch, S. A., Savage, M. O., Cavarzere, P., & Clark, A. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03511.x · Cited by 34
Davis, P. V., Franquemont, S., Liang, L., Angleson, J. K., & Dores, R. M. (2013) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2013.04.007 · Cited by 32
Fridmanis, D., Petrovska, R., Kalnina, I., Slaidina, M., Peculis, R., Schiöth, H. B., & Klovins, J. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.02.032 · Cited by 30
Turan, S., Hughes, C. R., Atay, Z., Güran, T., Haliloğlu, B., Clark, A., Bereket, A., & Metherell, L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2414 · Cited by 31
“loss-of function mutation previously shown to be trafficking defective (22) (Fig.”
BackgroundRoy, S., Roy, S. J., Pinard, S., Taillefer, L.-D., Rached, M., Parent, J.-L., & Gallo-Payet, N. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-0018 · Cited by 28
Quantitative Analysis of Signal Transduction with In-Cell Western Immunofluorescence Assays
Boveia, V. R., & Schutz-Geschwender, A. R. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2718-0_13 · Cited by 31
Barlock, T. K., Gehr, D. T., & Dores, R. M. (2014) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2014.03.045 · Cited by 28
Hughes, C. R., Chung, T., Habeb, A. M., Keleştimur, F., Clark, A., & Metherell, L. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2731 · Cited by 24
Hinkle, P. M., Serasinghe, M. N., Jakabowski, A., Sebag, J. A., Wilson, K. R., & Haskell‐Luevano, C. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.10.113 · Cited by 17
“Mutations in humanMC2 receptors are the most common cause of familial glucocorticoid deficiency, which is characterized by ACTH resistance, and most of the missense mutations that give rise to this disease interfere with receptor trafficking (Chung et al., 2008).”
Ren, J., Li, Y., Xu, N., Li, H., Li, C., Han, R., Wang, Y., Li, Z., Kang, X., Liu, X., et al. (2016) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2016.10.012 · Cited by 22
Abuduxikuer, K., Li, Z., Xie, X., Li, Y., Zhao, J., & Wang, J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00359 · Cited by 16
Jain, V., Metherell, L., David, A., Sharma, R., Sharma, P. K., Clark, A. J. L., & Chan, L. F. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0581 · Cited by 17
Dores, R. M., & Chapa, E. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.747843 · Cited by 16
“In addition, esMC2R could be fully activated with an analog of hACTH(1-24) in which the KKRR motif was replaced with alanines (37).”
BackgroundInfluentialFamilial glucocorticoid deficiency: a diagnostic challenge during acute illness
Habeb, A. M., Hughes, C. R., Alarabi, R. E. D. A., Al-Muhamadi, A., Clark, A. J. L., & Metherell, L. (2013) · European Journal of Pediatrics · doi:10.1007/s00431-013-2044-1 · Cited by 14
“The MC2R bearing this mutation has been shown to interact with MRAP, but despite this trafficks poorly to the plasma membrane and thus fails to bind ACTH [2].”
BackgroundYoo, H. (2021) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2142150.075 · Cited by 12
Hirsch, A., Meimaridou, E., Fernández‐Cancio, M., Pandey, A. V., Clemente, M., Audí, L., Clark, A., & Flück, C. E. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1056 · Cited by 13
“Cell surface expression of the HA-tagged MC2R constructs was monitoredbyacell surfaceassayusing fluorescent signals for readout (29).”
BackgroundInfluentialChan, L. F., Chung, T., Massoud, A. F., Metherell, L., & Clark, A. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0636 · Cited by 10
“Interestingly, functional analysis of the neighbouring amino acid R128C showed that this mutant traffics to the cell surface but fails to signal through loss of high-affinity binding (20, 21 ).”
BackgroundInfluentialFamilial Glucocorticoid Deficiency: the changing landscape of an eponymous syndrome
Maharaj, A. V. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1268345 · Cited by 9
Analyzing the activation of the melanocortin-2 receptor of tetrapods
Dores, R. M., & Liang, L. (2014) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2014.03.039 · Cited by 11
A Novel Homozygous MC2R Variant Leading to Type-1 Familial Glucocorticoid Deficiency
Mohammed, I., Haris, B., & Hussain, K. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac058 · Cited by 11
“Ile130Asn exhibited partial trafficking impairment [20].”
Jardine, D. S., Emond, M. J., Meert, K. L., Harrison, R. E., Carcillo, J. A., Anand, K. J. S., BERGER, J. T., Newth, C. J. L., Willson, D. F., Nicholson, C. E., et al. (2014) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000000193 · Cited by 9
Fernández, N. P., Gutiérrez, A. M., Pazos, B. T., Cros, A. T., Gandía, E. D., & Cabrera, Á. Z. (2023) · Annales d Endocrinologie · doi:10.1016/j.ando.2023.05.011 · Cited by 10
Davis, P. E., Wilkinson, E. C., & Dores, R. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174166 · Cited by 8
Structural determinants regulating cell surface targeting of melanocortin receptors
Rodrigues, A. R., Sousa, D., Almeida, H., & Gouveia, A. (2013) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0055 · Cited by 8
“MRAP were not disturbed (Chung et al. 2008).”
BackgroundStratakis, C. A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1650 · Cited by 7
“MC2R sequencing showed a homozygous T152K mutation that is known to affect trafficking of the receptor (31), like most ACTH receptor defects causing FGD.”
BackgroundChapter 5 The Molecular Basis of Adrenocorticotrophin Resistance Syndrome
Elias, L. L. K., & Clark, A. L. (2009) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(09)88005-8 · Cited by 8
Millar, R. P., Newton, C. L., & Roseweir, A. K. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-375097-6.10002-2 · Cited by 9
Familial glucocorticoid deficiency due to compound heterozygosity of two novel MC2R mutations
Aza‐Carmona, M., Bonis, A. C. B., Guerrero-Fernández, J., Casado, I. G., Gracía, R., & Heath, K. E. (2011) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2011.024 · Cited by 6
Davis, P. V., Shaughnessy, C. A., & Dores, R. M. (2022) · Biomolecules · doi:10.3390/biom12101422 · Cited by 5
Bouyoucos, I. A., Shaughnessy, C. A., Anderson, W. G., & Dores, R. M. (2023) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2023.114342 · Cited by 5
Liang, L., Davis, P. V., Dores, M. R., & Dores, R. M. (2017) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2017.05.003 · Cited by 4
“Chung et al. 2008 found that a spontaneous mutation at H 180 364 (highlighted in black) also disrupted activation of hMC2R.”
BackgroundInfluentialLiu, S., Zeng, T., Luo, C., Peng, D., Xu, X., Liu, Q., Wu, Q., Lu, Q., & Huang, F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1113234 · Cited by 4
“The mechanism underlying FGD1 involves unresponsiveness to ACTH due to defective trafficking of the receptor to the cell surface or impaired ligand binding (24).”
BackgroundHoglin, B. E., Miner, M. V., Erdenebayar, U., Shaughnessy, C. A., & Dores, R. M. (2023) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2023.114278 · Cited by 3
Familial Glucocorticoid Deficiency Presenting with Tonic-Clonic Seizure: A Case Report
Alghamdi, A. H. (2023) · Children · doi:10.3390/children10020301 · Cited by 2
“Microscopical examination of adrenal gland revealed marked atrophic changes in both zona fasciculata and zona reticularis, while no abnormalities were observed in zona glomerulosa [5].”
BackgroundMelanocortin/melanocortin receptors
Dores, R. M., Londraville, R. L., Prokop, J. W., Davis, P. V., Dewey, N., & Lesinski, N. (2014) · Journal of Molecular Endocrinology · Cited by 2
Gorvin, C. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00020-7 · Cited by 2
Molecular Genetics of Inherited Glucocorticoid Deficiency
Meimaridou, E., Kowalczyk, J., & Metherell, L. (2014) · Wiley eBooks · doi:10.1002/9780470015902.a0025368 · Cited by 2
Novel Melano-Cortin-2-Receptor Gene Mutation Presenting With Infantile Cholestasis: A Case Report
Alsaedi, A., Kamal, N. M., Bakkar, A., Althobaiti, E., Naeem, M., & Kamal, M. (2022) · Clinical Medicine Insights Case Reports · doi:10.1177/11795476221091387 · Cited by 1
Obesity and Stress: The Melanocortin Connection
Singhal, S., & Hill, J. W. (2018) · Springer eBooks · doi:10.1007/978-3-319-89506-2_11 · Cited by 2
Xing, Y., Achermann, J. C., & Hammer, G. D. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416006-4.00002-8 · Cited by 3
Solubilisation and characterisation of G-protein-coupled receptors using styrene maleic acid polymer
Charlton, J. (2016) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 2
Primary Adrenal Hypoplasia and ACTH Resistance Syndromes
Kyrou, I., & Tsigos, C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.98869-x
Davis, P. V. (2018) · Digital Commons - DU (University of Denver)
Xia, J., Jiao, Z., Zhao, Z., Wu, J., & Kong, X. (2020) · Pediatrics & Neonatology · doi:10.1016/j.pedneo.2020.10.013
Ferraz‐de‐Souza, B., Lin, L., & Achermann, J. C. (2009) · Yearbook of pediatric endocrinology · doi:10.1159/000239773
Xing, Y., Achermann, J. C., & Hammer, G. D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821424-4.00017-4 · Cited by 1
Disorders of the Adrenal Gland in Children and Adolescents
Katugampola, H., & Krone, N. P. (2023) · Endocrinology · doi:10.1007/978-3-030-18901-3_4-1
The repertoire of G‐protein‐coupled receptor variations in the Japanese population 54KJPN
Ikuta, T., Suzuki, R., & Inoue, A. (2024) · Genes to Cells · doi:10.1111/gtc.13164
“R 3x50 substitutions are known to cause loss-of-function (Barak et al., 2001; Chung et al., 2008; Topaloglu et al., 2007); thus, these variations will also be loss-of-function ones.”
Disorders of the Adrenal Gland in Children and Adolescents
Katugampola, H., & Krone, N. P. (2024) · Endocrinology · doi:10.1007/978-3-030-23709-7_4
Clinical and Genetic Mechanisms in Patients with MC2R Deficiency Presenting with Early Puberty
Özturan, E. K., Abalı, Z. Y., Karaman, V., Poyrazoğlu, Ş., Uyguner, Z. O., Darendelıler, F., & Baş, F. (2024) · Hormone Research in Paediatrics · doi:10.1159/000542307
“Defects in the MC2R gene cause FGD-1 [8].”
Chougula, P. V., Deshpande, S., Datar, C. A., & Suryawanshi, P. B. (2025) · BMJ Case Reports · doi:10.1136/bcr-2024-264598
Unmasking Isolated Glucocorticoid Deficiency: Clinical Insights From 2 Cases
Singhal, A., Menon, J. C., Yadav, S., Gupta, A., Gunna, S., & Bhatia, E. (2025) · JCEM Case Reports · doi:10.1210/jcemcr/luaf316
Arslan, E., Solmaz, A. E., Kızılay, D. Ö., Akın, H., Balkı, H. G., Jalilova, A., Gökşen, D., Darcan, Ş., & Özen, S. (2026) · Endocrine · doi:10.1007/s12020-026-04557-z · Cited by 1
“This variant’s functional significance is well-documented in vitro: partial receptor membrane trafficking and ACTH responsiveness have been observed for p.Arg128His, as described by Chung et al. [ 21 ].”
Metadata
- Authors
- Chung, T. T., Webb, T. R., Chan, L. F., Cooray, S. N., Metherell, L. A., King, P. J., Chapple, J. P., & Clark, A. J. L.
- Affiliations
- Queen Mary University of London (GB)
- Corresponding author
- Clark, A. J. L.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-12-01
- Volume
- 93
- Issue
- 12
- Pages
- 4948-4954
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC2635546
- OpenAlex
- W2018717551
- Cited by
- 82
- References
- 36
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 4 · 2023: 8 · 2022: 4 · 2021: 3 · 2020: 3 · 2019: 5 · 2018: 4 · 2017: 3 · 2016: 5 · 2015: 2 · 2014: 10 · 2013: 7 · 2012: 5
- FWCI
- 3.86
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- melanocortin 2 receptor, ACTH receptor, missense mutations, receptor trafficking, cell surface expression, MRAP, ACTH signaling, cAMP signaling, autosomal recessive disorder
- MeSH terms
- Cyclic AMP, Animals, Cell Line, Cricetulus, Glucocorticoids, Cricetinae, Humans, Ligands, Receptors, Cell Surface, Blotting, Western, Signal Transduction, Mutagenesis, Site-Directed, CHO Cells, Genes, Reporter, Microscopy, Confocal, Mutation, Missense, LDL-Receptor Related Protein-Associated Protein, Receptor, Melanocortin, Type 2, Immunoprecipitation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.